Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series.
about
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferretsHuman influenza A H5N1 in Indonesia: health care service-associated delays in treatment initiationInfluenza and the use of oseltamivir in childrenPopulations at risk for severe or complicated Avian Influenza H5N1: a systematic review and meta-analysisWhat is the optimal therapy for patients with H5N1 influenza?Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesMesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in miceAdjuvant efficacy of mOMV against avian influenza virus infection in mice.Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza.The challenges of global case reporting during pandemic A(H1N1) 2009Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1.Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.Oseltamivir in human avian influenza infection.Host response to influenza virus: protection versus immunopathology.Physician's knowledge, attitudes, and practices regarding seasonal influenza, pandemic influenza, and highly pathogenic avian influenza A (H5N1) virus infections of humans in IndonesiaHighly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic reviewFailure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.The need for strengthening the influenza virus detection ability of hospital clinical laboratories: an investigation of the 2009 pandemic.Oseltamivir in seasonal, pandemic, and avian influenza: a comprehensive review of 10-years clinical experience.Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.Recent advances in the diagnosis and treatment of influenza pneumonia.An overview of the highly pathogenic H5N1 influenza virus.Human H5N1 influenza infections in Cambodia 2005-2011: case series and cost-of-illnessInfluenza A H5N1 and HIV co-infection: case report.Broad cross-reactive epitopes of the H5N1 influenza virus identified by murine antibodies against the A/Vietnam/1194/2004 hemagglutinin.Rapamycin adjuvant and exacerbation of severe influenza in an experimental mouse modelA comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006.1918 and 2009 H1N1 influenza viruses are not pathogenic in birdsAvian influenza H5N1 transmission in households, Indonesia.Impact of education and network for avian influenza H5N1 in human: knowledge, clinical practice, and motivation on medical providers in Vietnam.Surveillance of influenza in Indonesia, 2003–2007.Clinical factors associated with severity in hospitalized children infected with avian influenza (H5N1).The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in EgyptSeroprevalence of antibodies to highly pathogenic avian influenza A (H5N1) virus among close contacts exposed to H5N1 cases, China, 2005-2008.The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins.Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases.Antibody responses and cross protection against lethal influenza A viruses differ between the sexes in C57BL/6 mice.The East Jakarta Project: surveillance for highly pathogenic avian influenza A(H5N1) and seasonal influenza viruses in patients seeking care for respiratory disease, Jakarta, Indonesia, October 2011-September 2012.Knowledge, Attitudes, and Practices (KAP) Relating to Avian Influenza (H10N8) among Farmers' Markets Workers in Nanchang, ChinaInhaled nitric oxide therapy fails to improve outcome in experimental severe influenza
P2860
Q21142658-278E6535-7605-404A-8A60-B6543E669D6BQ21257264-8F34568B-3DBF-447E-BBFA-BC70619FDD68Q26739661-F8AB9DF7-7CA5-4F10-99FC-48CA6C8B1473Q27016462-3BCC5C8C-9B07-45D7-87C2-AADC6A9F9802Q28475630-2F7685FC-FEE6-459A-9ABA-CEAC25CD1D57Q28479036-B8C192C8-8471-454B-B19A-352DF9AD0A8FQ28596834-E2CA9269-2491-46FD-A79B-8EC547088C47Q30219688-B2CB5E82-B7DA-4E15-8AD4-DBF6621E891CQ30353064-891E0392-480D-46DB-9E50-9667364D21BFQ30357533-0BB472A5-E854-46A8-A5DF-EF22126CC878Q30358617-10798F6F-6A9E-41FA-9848-40F5CB011983Q30379095-ABCAC2A1-4E77-48C4-B2CB-7D9FB45B7F54Q30386487-2C665707-C443-4036-AEE2-1BBF5380882BQ30391010-2A6CE2F2-2457-4963-AA71-2C37B479C72CQ30392160-17566661-AB55-4C0A-97D5-B7A6DB91588FQ30399171-831C50FE-6F18-4880-9BA5-9CBC28EA6884Q30399530-8FDB4313-6526-423F-B071-EB354F89F089Q30399768-DF54FC4F-3647-459E-9AE3-FFB6F89D2D44Q30409023-A8CDC0B7-5428-4212-8152-A18AB84CB49BQ30409873-BFDD36BB-C991-4E00-A3BB-65B1876B349EQ30415002-B2D9479F-954B-44EE-B996-92929671DDCDQ30426011-9D72EA6E-2CDB-41B5-A1D7-1109162B3C7FQ30431488-A0F8D0D3-BB49-4C50-A0EB-9E8932B54D0BQ33602093-F33FD2E2-5328-466A-ABAD-452F507E05FCQ33778797-B6BD023A-8C41-4208-981B-2126402A31EEQ33829962-8EED87A2-FE02-454D-A702-754EFA0B1C91Q33894593-11F0D99E-2FCA-42D9-84BB-18D31E202C59Q33923882-05C1F560-3DB4-403C-BF24-2373C824977CQ34125386-95546359-D958-407B-B705-D04026DCFD09Q34146032-F8121CBD-FF2C-4C54-AF0D-4D1FA7CE6B9CQ34340213-FE207F3A-BC0A-4B6C-A8F3-1E59D6A03C7FQ34393865-9D2DDE5A-A567-4E04-BAD1-CEBB2312A857Q34703972-7908FD6D-6DCF-4CC5-82B9-28F6008E40F4Q34964435-18DD9A31-4951-44BD-9F58-64B3DBA5F48BQ35077820-7037471D-F9B9-42F1-BDE0-55EBAFCEA2A5Q35131163-89C59EFC-4119-4066-A56E-0A1913712BDDQ35503099-2CDC0283-3E5D-4E44-BBDE-C76D5DDC3159Q35614461-0C3365DE-C01A-4382-B75E-8F91DD0CBB54Q35620626-74A477CD-6A98-47CF-972F-86D659745FE8Q35673516-74B30CE7-A96C-48C7-AB76-0F924BF595E1
P2860
Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Factors associated with case f ...... s in Indonesia: a case series.
@ast
Factors associated with case f ...... s in Indonesia: a case series.
@en
type
label
Factors associated with case f ...... s in Indonesia: a case series.
@ast
Factors associated with case f ...... s in Indonesia: a case series.
@en
prefLabel
Factors associated with case f ...... s in Indonesia: a case series.
@ast
Factors associated with case f ...... s in Indonesia: a case series.
@en
P2093
P1433
P1476
Factors associated with case f ...... s in Indonesia: a case series.
@en
P2093
Chita Septiawati
Elvieda Sariwati
Erna Tresnaningsih
I Nyoman Kandun
Syahrial Harun
Tetty Setiawati
Toni Wandra
Vernon Lee
Wilfried H Purba
P304
P356
10.1016/S0140-6736(08)61125-3
P407
P50
P577
2008-08-14T00:00:00Z